Related Experiment Videos

Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic

M Buerke1, D Prüfer, M Dahm

  • 1II. Department of Medicine, Johannes Gutenberg University, Mainz, Germany.

Insights

Exogenous C1 esterase inhibitor (C1 INH) protects against myocardial ischemia-reperfusion injury by blocking complement activation and reducing inflammatory cell adhesion. This treatment significantly reduces cardiac damage and neutrophil infiltration in rat models.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pharmacology

Background:

  • Myocardial ischemia-reperfusion (I+R) injury involves leukocyte activation, cytokine release, and complement system activation.
  • These processes contribute to significant cardiac damage following reduced blood flow and subsequent re-perfusion.

Purpose of the Study:

  • To investigate the cardioprotective effects of exogenous C1 esterase inhibitor (C1 INH) in a rat model of myocardial I+R.
  • To elucidate the mechanisms underlying C1 INH's potential protective role.

Main Methods:

  • A rat model of myocardial I+R (20 min ischemia, 24 or 48 hr reperfusion) was utilized.
  • C1 INH was administered intravenously prior to reperfusion.
  • Myocardial injury was assessed by histology and myeloperoxidase (MPO) activity.
  • Immunohistochemistry was used to evaluate complement C1q deposition and adhesion molecule expression (P-selectin, ICAM-1).

Main Results:

  • C1 INH administration significantly attenuated myocardial injury and reduced MPO activity (a marker of neutrophil infiltration) after 24 hr of reperfusion.
  • Significant cardioprotection and reduced neutrophil infiltration were also observed after 48 hr of reperfusion with C1 INH.
  • C1 INH treatment abolished the deposition of C1q and the expression of P-selectin and ICAM-1 on cardiac vasculature.

Conclusions:

  • Exogenous C1 INH demonstrates significant cardioprotective effects against myocardial I+R injury.
  • The protective mechanisms involve blocking the classical complement pathway and reducing the expression of endothelial adhesion molecules.
  • This leads to decreased polymorphonuclear leukocyte (PMN) interaction with the endothelium and diminished cardiac necrosis.

Related Concept Videos